Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Continuation in OPCAB Surgery
NCT02209909Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in coronary artery disease (CAD) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change from baseline in platelet p-selectin at 48 hours. Started Jul 2014; status: completed.
02
Drugs
aspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02209909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209909.